Literature DB >> 2773842

Methodologic issues in studying behavioral effects of infant iron-deficiency anemia.

B Lozoff1.   

Abstract

Methodologic challenges proving that iron-deficiency anemia (IDA) adversely affects infant behavior and development are examined. This community-based study in Costa Rica included 191 infants aged 12-23 mo with varying degrees of iron deficiency. The Bayley Scales of Infant Development were administered before and both 1 wk and 3 mo after intramuscular or oral administration of iron. Appropriate placebo-treatment control infants were also tested. Infants with IDA showed significantly lower mental and motor test scores, even after factors relating to birth, nutrition, family background, parental IQ, and the home environment were considered. The methodologic issues raised by the study point to the need to assess behavioral effects in a prospective, randomized trial of measures to prevent iron-deficiency anemia in infancy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2773842     DOI: 10.1093/ajcn/50.3.641

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  4 in total

1.  Combating anemia: the greatest challenge to the medical fraternity.

Authors:  Umesh Kapil
Journal:  Indian J Pediatr       Date:  2010-12-01       Impact factor: 1.967

2.  Changes in haemoglobin levels in infants in Malawi: effect of low birth weight and fetal anaemia.

Authors:  S le Cessie; F H Verhoeff; G Mengistie; P Kazembe; R Broadhead; B J Brabin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-05       Impact factor: 5.747

3.  Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials.

Authors:  Amreen Naqash; Rifat Ara; Ghulam N Bader
Journal:  BMC Womens Health       Date:  2018-01-05       Impact factor: 2.809

Review 4.  Prevention of iron deficiency anemia in infants and toddlers.

Authors:  Sripriya Sundararajan; Heike Rabe
Journal:  Pediatr Res       Date:  2020-04-24       Impact factor: 3.756

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.